Clemens Kamrath

Clemens Kamrath

Auto-generated profile, based on publicly available information

Clemens Kamrath

Department of Pediatrics, Adolescent Medicine and Neonatology, University of Freiburg Faculty of Medicine, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2020 in JAMA
Verified
Journal Article
Open access
PDF file
CKClemens Kamrath
Clemens Kamrath
KMKirsten Mönkemöller
Kirsten Mönkemöller
TBTorben Biester
Torben Biester
TRTilman R. Rohrer
Tilman R. Rohrer
KWKatharina Warncke
Katharina Warncke
RHReinhard W. Holl
Reinhard W. Holl
During the coronavirus disease 2019 (COVID-19) pandemic, a significantly lower rate of health care use has been reported, potentially leading to delayed medical care.1 Diabetic ketoacidosis is an acute life-threatening complication of a delayed diagnosis of type 1 diabetes.2 We investigated the frequency of diabetic ketoacidosis in children and adolescents at diagnosis of type 1 diabetes in Germany during the first 2 months of the COVID-19 pandemic.

1 March 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
CKClemens Kamrath
Clemens Kamrath
ZHZe'EV Hochberg
Ze'EV Hochberg
MHMichaela F. Hartmann
Michaela F. Hartmann
TRThomas Remer
Thomas Remer
SWStefan A. Wudy
Stefan A. Wudy
17-Hydroxyprogesterone (17-OHP) can be converted to dihydrotestosterone (DHT) via an alternative "backdoor" route that bypasses the conventional intermediates androstenedione and testosterone. In this backdoor pathway, 17-OHP is converted to 5α-pregnane-3α,17α-diol-20-one (pdiol), which is an excellent substrate for the 17,20 lyase activity of CYP17A1 to produce androsterone. OBJECTIVE AND HYPOTHESES: The objective of this study was to obtain evidence for the presence of the backdoor pathway in patients with 21-hydroxylase deficiency (21-OHD). We compared urinary steroid hormone profiles determined by gas chromatography-mass spectrometry of 142 untreated 21-OHD patients (age range, 1 d to 25.4 yr; 51 males) with 138 control subjects. The activity of the backdoor pathway was assessed using the ratios of the urinary concentrations of pdiol to those of the metabolites of the classic Δ4 and Δ5 pathways. In contrast to etiocholanolone, which originates almost exclusively from the classic pathways, androsterone may be derived additionally from the backdoor pathway. Therefore, the androsterone to etiocholanolone ratio can be used as an indicator for the presence of the backdoor pathway. Untreated 21-OHD subjects showed increased urinary ratios of pdiol to the Δ4 and Δ5 pathway metabolites and a higher androsterone to etiocholanolone ratio. The elevated ratios of pdiol to the Δ4 and Δ5 pathway metabolites as well as the higher androsterone to etiocholanolone ratio in patients with 21-OHD indicate postnatal activity of the backdoor pathway with maximum activity during early infancy. Our data provide new insights into the pathophysiology of androgen biosynthesis of 21-OHD.

21 August 2020 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
STSascha Tittel
Sascha Tittel
JRJoachim Rosenbauer
Joachim Rosenbauer
CKClemens Kamrath
Clemens Kamrath
JZJulian Ziegler
Julian Ziegler
FRFelix Reschke
Felix Reschke
RHReinhard Walter Holl
Reinhard Walter Holl

26 July 2022 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CKClemens Kamrath
Clemens Kamrath
JRJoachim Rosenbauer
Joachim Rosenbauer
AEAlexander J. Eckert
Alexander J. Eckert
KSKai Siedler
Kai Siedler
HBHeike Bartelt
Heike Bartelt
RHReinhard W. Holl
Reinhard W. Holl
OBJECTIVE: The aim of this study was to investigate the incidence of type 1 diabetes in children and adolescents during the coronavirus disease 2019 (COVID-19) pandemic in Germany compared with previous years. RESEARCH DESIGN AND METHODS: Based on data from the multicenter German Diabetes Prospective Follow-up Registry, we analyzed the incidence of type 1 diabetes per 100,000 patient-years in children and adolescents from 1 January 2020 through 30 June 2021. Using Poisson regression models, expected incidences for 2020/21 were estimated based on the data from 2011 to 2019 and compared with observed incidences in 2020/21 by estimating incidence rate ratios (IRRs) with 95% CIs. RESULTS: From 1 January 2020 to 30 June 2021, 5,162 children and adolescents with new-onset type 1 diabetes in Germany were registered. The observed incidence in 2020/21 was significantly higher than the expected incidence (24.4 [95% CI 23.6–25.2] vs. 21.2 [20.5–21.9]; IRR 1.15 [1.10–1.20]; P < 0.001). IRRs were significantly elevated in June 2020 (IRR 1.43 [1.07–1.90]; P = 0.003), July 2020 (IRR 1.48 [1.12–1.96]; P < 0.001), March 2021 (IRR 1.29 [1.01–1.65]; P = 0.028), and June 2021 (IRR 1.39 [1.04–1.85]; P = 0.010). CONCLUSIONS: A significant increase in the incidence of type 1 diabetes in children was observed during the COVID-19 pandemic, with a delay in the peak incidence of type 1 diabetes by ∼3 months after the peak COVID-19 incidence and also after pandemic containment measures. The underlying causes are yet unknown. However, indirect rather than direct effects of the pandemic are more likely to be the cause.

1 January 2021 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
CKClemens Kamrath
Clemens Kamrath
STSascha R Tittel
Sascha R Tittel
TKThomas M Kapellen
Thomas M Kapellen
TBThekla von Dem Berge
Thekla von Dem Berge
BHBettina Heidtmann
Bettina Heidtmann
RHReinhard W Holl
Reinhard W Holl